Carson City, Nevada–(Newsfile Corp. – March 24, 2022) – Pharmagreen Biotech, Inc., (OTCQB: PHBI), (“Pharmagreen” or the “Company“) is pleased to report ongoing business developments with...
Carson City, Nevada–(Newsfile Corp. – January 20, 2022) – Pharmagreen Biotech, Inc. (OTCQB: PHBI) (“Pharmagreen” or the “Company“), is pleased to announce that it completed another...
Carson City, Nevada–(Newsfile Corp. – January 6, 2022) – Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed memorandum of understanding (MOU) to acquire Long Valley...
Carson City, Nevada–(Newsfile Corp. – December 21, 2021) – Pharmagreen Biotech Inc., (OTCQB: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD Hemp...
Carson City, Nevada–(Newsfile Corp. – December 2, 2021) – Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik. The update...
Carson City, Nevada–(Newsfile Corp. – November 11, 2021) – Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to announce that in advance of its entry into...
Carson City, Nevada–(Newsfile Corp. – November 4, 2021) – Pharmagreen Biotech, Inc. (OTC PINK: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD...
Carson City, Nevada–(Newsfile Corp. – September 29, 2021) – Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to update its shareholders on the company’s Regulation A...
Carson City, Nevada–(Newsfile Corp. – July 28, 2020) – Pharmagreen Biotech, Inc. (PHBI), a company specializing in the development of high quality tissue cultured starter plantlets...